Ixaka develops proprietary cell and gene therapies which enhance the inherent therapeutic power of cells.
These therapies can treat and potentially cure serious diseases which currently have limited treatment options by targeting curative cells to the site of disease and by directly modifying cells within the body to improve their therapeutic action.